Cargando…
Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?
Down syndrome (DS), also known as “trisomy 21”, is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. Silencing these extra genes is beyond existing technology and seems to be impractical. A number of pharmacologic options have been proposed to change the qual...
Autores principales: | Wyganowska-Świątkowska, Marzena, Matthews-Kozanecka, Maja, Matthews-Brzozowska, Teresa, Skrzypczak-Jankun, Ewa, Jankun, Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796196/ https://www.ncbi.nlm.nih.gov/pubmed/29342922 http://dx.doi.org/10.3390/ijms19010248 |
Ejemplares similares
-
Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review)
por: Wyganowska-Świątkowska, Marzena, et al.
Publicado: (2019) -
Effects of chlorhexidine, essential oils and herbal medicines (Salvia, Chamomile, Calendula) on human fibroblast in vitro
por: Wyganowska-Swiatkowska, Marzena, et al.
Publicado: (2016) -
Can components of the plasminogen activation system predict the outcome of kidney transplants?
por: Jankun, Jerzy, et al.
Publicado: (2018) -
Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives
por: PARSAI, SHIREEN, et al.
Publicado: (2014) -
Isolation and characterization of serum albumin from Camelus dromedarius
por: MALIK, AJAMALUDDIN, et al.
Publicado: (2013)